The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identification and targeting of M-phase progression downstream of HER2 in trastuzumab-sensitive and -resistant breast cancer cell lines.
E. Aubrey Thompson
No relevant relationships to disclose
Brian M. Necela
No relevant relationships to disclose
Jennifer M. Carr
No relevant relationships to disclose
Jennifer M. Kachergus
No relevant relationships to disclose
Daniel Serie
No relevant relationships to disclose
Krishna R. Kalari
No relevant relationships to disclose
Yan W. Asmann
No relevant relationships to disclose
Edith A. Perez
No relevant relationships to disclose